Paper submission opens – 15 Feb, 2019
Paper Submission is Closed!
Paper accept/reject notification – 31 July, 2019

Abstract Categories

  • Acute kidney injury: clinical, drugs, AKI-CKD continuum
  • Acute kidney injury: experimental models and biomarkers
  • Anaemia and iron management
  • Apheresis
  • Bioethics, palliative care and quality of life in dialysis
  • Bone and mineral metabolism
  • Chronic kidney disease diagnosis, classification and progression
  • Complications of CKD
  • Complications of dialysis
  • CRRT and related therapies
  • Diet and nutrition
  • ECMO
  • Epidemiology, outcomes and health service research in CKD
  • Epidemiology, outcomes and health services research in dialysis
  • Extracorporeal Sepsis management
  • Green’ nephrology and environmental sustainability
  • Haemodialysis and hemodiafiltration
  • Ketoanalogues in CKD
  • Other extracorporeal therapies, devices, poisoning and other technology
  • Paediatric nephrology
  • Peritoneal dialysis
  • Pharmacologic interventions in Sepsis
  • Probiotics in CKD
  • Sarcopenia
  • Vascular access
  • Miscellaneous

Submission Process
The abstract submission process for ISBP-PDSICON 2019 will be open soon.

Presenting Authors are requested to create an account and submit an abstract for review according to the guidelines set out below. The same account will be used when you register for the conference. Please keep the email and password used to create the account for future use. Please do not create a new account. Should you require any assistance or have a query about online submission, contact [email protected]

IMPORTANT:
It is ESSENTIAL that you read the instructions below before you submit.
The Presenting Author must submit the abstract and is required to be the corresponding author for that abstract
Abstracts must be submitted in English
If you have any queries please contact [email protected]

Presentation Type
An abstract can be submitted for presentation at the Conference as one of the following categories:

  • Oral Presentation
  • E-Poster Presentation

At the review stage, the Programme Committee may change the presentation type submitted by the author to ensure the continuity of the conference programme i.e. oral presentation may be changed to poster presentation OR poster presentation to oral presentation. The presenting Author will be informed of any change to their submitted presentation type at the acceptance notification stage. The decision of the programme committee is final.

Oral Format:
Oral presentations will be 8-10 minutes long.

Poster Format:
Accepted posters will be asked to produce a E-poster for display at the conference.

Submission Process:
The online abstract submission system is a simple step by step process and will ask you to input the following details:

  • Title of the abstract (word limit is 10)
  • Presentation type (Oral, Poster & Flash Presentation, Poster)
  • Theme must be chosen from the theme list
  • Name, affiliation, and job title of Presenting Author (this person will act as the main contact for this abstract; this person must be listed as the first author)
  • Name, affiliation, and job title of co-author(s)
  • Abstract word limit is 500, excluding Title, Authors and Affiliations
  • Please indicate in the Additional Information if you are a PhD student, if you are an Early Career Scientist, and please provide keywords which are appropriate to your abstract.

SCHOLARSHIP AWARDS FOR THE TOP 2 ORAL AND POSTER ABSTRACTS SUBMISSIONS!

ISBP-PDSICON 2019 is pleased to offer 2 Best Abstract Awards for ORAL and 2 Best Abstract Awards for POSTER.

ISBP-PDSI PAPER AWARDS
Cash prizes for the 3 best papers at the 37th Congress of the ISBP and 22nd Annual Conference of PDSI!
1st prize*
USD 1000
2nd prize*
USD 500
3rd prize*
USD 500
Commemorative plaques to all the winners
&
5* Travel Grants

*Abstracts will be published in Blood Purification Journal

ELIGIBILITY CRITERIA
In order to be eligible for a Best Abstract Awards, candidates must be the presenting author of an accepted abstract and register and attend the Congress.